W. L. Gore & Associates (Gore) is announcing that Royal Sussex County Hospital in Brighton, is the first medical center in the UK to enroll a patient in the Gore REDUCE Clinical Study. The study is an FDA approved prospective, randomized, multi-center, international trial designed to demonstrate safety and effectiveness of the GORE HELEX Septal Occluder for PFO closure in patients with a history of cryptogenic stroke or imaging-confirmed transient ischemic attack (TIA). The unique study … [Read more...] about UK Hospital Patient Participating in Gore Clinical Study
septal occluder
WL Gore Product Helping Heart Patients
W.L Gore and Associates (Gore) is reporting that it has received zero accounts of erosion of the aortic root or the free wall of the atrium associated with the worldwide use of the GORE HELEX Septal Occluder. The positive data comes from more than a decade of clinical experience using the Gore Device. Encouraging news for the thousands of patients treated with the GORE HELEX Septal Occluder to close the genetic condition of atrial septal defect (ASD), an abnormal hole in the wall between the … [Read more...] about WL Gore Product Helping Heart Patients
